ABIVAX Société Anonyme (EPA:ABVX)
85.10
-3.20 (-3.62%)
Nov 5, 2025, 5:35 PM CET
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €6.43 billion as of November 5, 2025. Its market cap has increased by 956.42% in one year.
Market Cap
6.43B
Enterprise Value
6.47B
Revenue
6.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
€85.10
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 6.43B, an increase of 3,081.88%. That is a compound annual growth rate of 39.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 6.43B | 1,402.10% |
| Dec 31, 2024 | 428.15M | -30.40% |
| Dec 29, 2023 | 615.18M | 493.46% |
| Dec 30, 2022 | 103.66M | -77.81% |
| Dec 31, 2021 | 467.16M | -1.83% |
| Dec 31, 2020 | 475.89M | 79.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 145.91B |
| Sanofi | 105.02B |
| Sartorius Stedim Biotech | 19.50B |
| bioMérieux | 12.90B |
| Eurofins Scientific SE | 10.61B |
| Ipsen | 10.20B |
| Virbac | 2.90B |
| emeis Société anonyme | 2.20B |